Detection of Clostridium difficile in Around 45 Minutes
Business Development Opportunities
Cepheid – Your Partner of Choice in Molecular Diagnostics
Healthcare Associated Infections
Accurate Detection of MRSA and SA in Positive Blood Culture Specimens in About an Hour
Critical Infectious Diseases
Enhanced performance in detecting drug-sensitive and -resistant Tuberculosis cases in less than 80 minutes
Go beyond just testing for Isoniazid (INH) resistance and detect mutations associated with resistance to 6 drugs used for TB treatment in a single test in <90 mins
Actionable, rapid respiratory results to meet the challenges of the ongoing pandemic.
Rapid detection and differentiation of Flu A, Flu B, or RSV in as soon as 20 minutes.^
A rapid, near-patient test for the detection of the 2019 novel coronavirus that causes COVID-19.
Actionable rapid respiratory results to meet the challenges of the ongoing pandemic.
Women's Health & Sexual Health
Rapid intrapartum Group B Streptococcus (GBS) testing with results as early as 30 minutes with EAT
A molecular point-of-care test that delivers actionable results in around 90 minutes
Detection and quantification of Human Immunodeficiency Virus type 1 (HIV-1) in around 90 minutes
Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)
Sensitive and quantitative monitoring of BCR-ABL p190 and ABL mRNA in patients with chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL)
Detection of the presence of bladder cancer in patients with hematuria in 90 minutes
Qualitative monitoring for recurrence in patients previously diagnosed with bladder cancer in 90 minutes
Standardized breast cancer ESR1/PGR/ERBB2/MKi67 mRNA biomarker assessment in less than two hours